Mounting an effective host immune response without incurring inflammatory injury requires the precise regulation of cytokine expression 1,2 . To achieve this, cytokine mRNAs are posttranscriptionally regulated by diverse RNA-binding proteins and microRNAs (miRNAs) targeting their 3´ untranslated regions (UTRs) 3,4 . Zcchc11 (zinc-finger, CCHC domain-containing protein 11) contains RNA-interacting motifs 5 , and has been implicated in signalling pathways involved in cytokine expression 6 . The nature of the Zcchc11 protein and how it influences cytokine expression are unknown. Here we show that Zcchc11 directs cytokine expression by uridylating cytokine-targeting miRNAs. Zcchc11 is a ribonucleotidyltransferase with a preference for uridine and is essential for maintaining the poly(A) tail length and stability of transcripts for interleukin-6 (IL-6) and other specific cytokines. The miR-26 family of miRNAs targets IL-6, and the addition of terminal uridines to the miR-26 3´ end abrogates IL-6 repression. Whereas 78% of miR-26a sequences in control cells contained 1-3 uridines on their 3´ ends, less than 0.1% did so in Zcchc11-knockdown cells. Thus, Zcchc11 fine tunes IL-6 production by uridylating miR-26a, which we propose is an enzymatic modification of the terminal nucleotide sequence of mature miRNA as a means to regulate gene expression.
Mounting an effective host immune response without incurring inflammatory injury requires the precise regulation of cytokine expression 1,2 . To achieve this, cytokine mRNAs are posttranscriptionally regulated by diverse RNA-binding proteins and microRNAs (miRNAs) targeting their 3´ untranslated regions (UTRs) 3, 4 . Zcchc11 (zinc-finger, CCHC domain-containing protein 11) contains RNA-interacting motifs 5 , and has been implicated in signalling pathways involved in cytokine expression 6 . The nature of the Zcchc11 protein and how it influences cytokine expression are unknown. Here we show that Zcchc11 directs cytokine expression by uridylating cytokine-targeting miRNAs. Zcchc11 is a ribonucleotidyltransferase with a preference for uridine and is essential for maintaining the poly(A) tail length and stability of transcripts for interleukin-6 (IL-6) and other specific cytokines. The miR-26 family of miRNAs targets IL-6, and the addition of terminal uridines to the miR-26 3´ end abrogates IL-6 repression. Whereas 78% of miR-26a sequences in control cells contained 1-3 uridines on their 3´ ends, less than 0.1% did so in Zcchc11-knockdown cells. Thus, Zcchc11 fine tunes IL-6 production by uridylating miR-26a, which we propose is an enzymatic modification of the terminal nucleotide sequence of mature miRNA as a means to regulate gene expression.
Zcchc11 is a member of the DNA polymerase β-like (pol β) nucleotidyltransferase superfamily 5 and it interacts with adaptor proteins in the Toll-like receptor (TLR) signalling pathway 6 . Overexpression of a truncated form of Zcchc11 (containing amino acids 191-625 of the 1644 amino acids, including only the first 2 of the 7 domains of interest identified in Fig. 1a ) decreased expression of the cytokines IL-6 and TNF-α 6 . The degree to which this truncation mutant conferred gain-or loss-offunction was unclear, indicating that Zcchc11 mediates cytokine expression without illuminating the mechanism(s) by which it performs this function. Zcchc11 contains domains capable of interacting with RNA, suggesting that the mechanism(s) for regulating cytokine expression may extend beyond its interaction with adaptors. As depicted in Fig. 1a , these domains include a CCHH zinc finger, which typically interacts with RNA or DNA; two poly(A) polymerase/25-oligoadenylate synthetase (PAP/25A)-associated domains, common in RNA-modifying enzymes 7 ; three CCHC zinc knuckles, often RNA-binding domains 8, 9 and a pol β domain, which usually mediates nucleotidyltransferase activity 5 . The putative pol β catalytic domain of Zcchc11 is highly conserved across genomes from a wide spectrum of eukaryotes (Fig.1b ). This primary structure suggests that Zcchc11 might be a ribonucleotidyltransferase.
Several proteins with homology to Zcchc11 are categorized as noncanonical poly(A) polymerases, including the Caenorhabditis elegans protein GLD-2 (defective in germline development 2; ref. 10 ) and the Schizosaccharomyces pombe proteins Cid1 and Cid13 (caffeine-induced death protein 1 and 13; refs 11, 12) . To determine whether Zcchc11 possesses such activity, we generated recombinant epitope-tagged wild-type Zcchc11 as well as a mutant form (Zcchc11 DADA) in which two aspartate residues predicted to be essential for catalysis 13 were mutated to alanines ( Fig. 1b ). Recombinant epitope-tagged Zcchc11 showed nucleotidyltransferase activity towards all RNA substrates examined (Fig. 1c) . In contrast, the DADA mutant showed no transfer of adenosine to RNA, implicating the pol β domain as responsible ( Fig. 1c ). Endogenous Zcchc11, immunoprecipitated from a human lung epithelial cell line (A549), also showed nucleotidyltransferase activity ( Supplementary Information, Fig. S1a ). The radiolabelled product was sensitive to RNase digestion, confirming RNA as the substrate of the enzyme ( Supplementary Information, Fig. S1b ). These data show that Zcchc11 is a ribonucleotidyltransferase enzyme whose activity is dependent on a conserved catalytic site.
Some pol β family members were recently identified as poly(U) polymerases 14, 15 . Thus, we examined nucleotides other than ATP (adenosine triphosphate) in Zcchc11 assays. Both endogenous ( Fig. 1d ) and recombinant epitope-tagged ( Supplementary Information, Fig. S1c ) forms of Zcchc11 showed the greatest nucleotidyltransferase activity with UTP (uridine triphosphate), followed by CTP (cytidine triphosphate), ATP and then GTP (guanosine triphosphate). The inclusion of an ATP regenerating system, designed to circumvent ATP loss from potentially co-precipitating ATPases, did not enhance adenosine incorporation (data not shown). As with adenylation, the uridylation activity of Zcchc11 did not show RNA substrate specificity, determined by the labelling of diverse RNA moieties, including an RNA ladder ( Fig. 1e ). These results indicate that Zcchc11 catalyses non-selective, template-independent uridylation of RNA.
Although Zcchc11 mRNA was ubiquitous among mouse tissues (data not shown), Zcchc11 protein was tissue-specific, and most prominently expressed in the thymus, spleen, testes and lung ( Supplementary  Information, Fig. S1d ). Zcchc11 was also expressed in human and mouse lung alveolar epithelial cell lines (A549 and MLE-15, respectively; Supplementary Information, Fig. S1e ). Expression of Zcchc11 in immune and mucosal cells pointed again to potential roles in cytokine regulation. Effective knockdown in A549 and MLE-15 cells by Zcchc11-targeting siRNA relative to control, non-targeting siRNA was confirmed by immunoblotting using siRNAs specific to human or mouse Zcchc11 (Fig. 2a ). Cell supernatants were collected from control or Zcchc11 siRNA-treated A549 cells stimulated with TNF-α (tumour necrosis factor-α; a promoter of inflammatory response), and cytokine expression was analysed. A subset of cytokines, IL-6, VEGF, TGF-α and RANTES, was substantially decreased by loss of Zcchc11 (Fig. 2b) . In contrast, fractalkine, IP-10, MCP-1, G-CSF and GM-CSF levels were not significantly affected, and IL-8 concentrations were increased (Fig. 2b) . These cytokine-specific effects were not unique to A549 cells, but were also observed in HEK 293T cells treated with control non-targeting or Zcchc11-targeting siRNA before TNF-α treatment (data not shown). The effects of Zcchc11 knockdown on IL-6 elaboration by A549 cells was examined over time after TNF-α treatment. Zcchc11 depletion led to decreased IL-6 at all time points examined, with the difference between depleted and control cells increasing over time ( Fig. 2c ). Zcchc11dependent effects on IL-6 expression were not unique to TNF-α stimulation, as Zcchc11 depletion similarly diminished IL-6 production elicited by Eschericia coli ( Supplementary Information, Fig. S2a ). As with results obtained in human A549 cells, IL-6 expression was decreased in murine MLE-15 cells by knockdown using a different siRNA targeting mouse Zcchc11 (Fig. 2d ). Thus, these results were not specific to a given siRNA sequence and were consistent across species and stimuli.
To determine whether Zcchc11 influenced cytokine expression at the mRNA level, we first measured steady-state transcripts. IL-6 mRNA was decreased by Zcchc11 knockdown (Fig. 2e ). Cytokine transcript stability was subsequently assessed, showing mRNA half-life for IL-6 to be decreased by Zcchc11 knockdown (Fig. 2f ). The effects of Zcchc11 knockdown on the stability of transcripts for other cytokines generally mirrored the effects of Zcchc11 knockdown on cytokine protein content ( Supplementary Information, Fig. S2b ). These data suggest that Zcchc11 mediates cytokine expression at the post-transcriptional level by influencing mRNA stability.
The poly(A) tail length of eukaryotic mRNAs is a critical determinant of transcript stability and translational efficiency 16, 17 . By any of three independent measurement methods 18 , the poly(A) tails on IL-6 mRNA were shortened due to Zcchc11 knockdown ( Fig. 2g ; Supplementary  Information, Fig. S2c, d ). Other Zcchc11-dependent cytokines examined also demonstrated shorter poly(A) tails due to Zcchc11 knockdown ( Supplementary Information, Fig. S2e ), whereas tail lengths for cytokines not decreased at the protein or mRNA stability levels were not shortened ( Supplementary Information, Fig. S2f ). In summary, decreasing Zcchc11 levels results in shorter poly(A) tails on only those cytokines whose transcript stability and maximal protein expression require Zcchc11. Poly(A) tail length, therefore, seems to be the step at which Zcchc11 directly or indirectly mediates cytokine expression. Because of its uridyltransferase activity, we considered whether Zcchc11 might uridylate the 3 polyadenylate terminus of mRNAs, as was observed for the Zcchc6 homologue of Zcchc11 (ref. 14) . IL-6 transcripts were isolated, cloned and sequenced from control and Zcchc11-knockdown A549 cells, but no terminal uridines were observed ( Supplementary Information, Fig. S3 ). Given these results and the enzymatic activity of Zcchc11, we considered alternative RNA substrates that could influence transcript poly(A) tail length and stability.
mRNA deadenylation and degradation can be stimulated by miRNAs 19, 20 , leading us to reason that the RNA-modifying Zcchc11 enzyme may alter cytokine expression through an miRNA-dependent mechanism. Consistent with this hypothesis, it has been observed that miRNAs often contain untemplated nucleotides on their 3 ends, primarily adenosines or uridines [21] [22] [23] . The Zcchc11-related cytoplasmic poly(A) polymerase GLD-2 (ref. 24 ) is capable of adenylating the 3 end of mature miRNA, but no enzyme has yet been identified as responsible for the uridylation of mature miRNA. Analyses using TargetScan [25] [26] [27] revealed that the 3UTR of IL-6 mRNA contains a highly conserved region potentially targeted by the miR-26 family of miRNAs ( Fig. 3a) , which lies in close proximity to an AU-rich region and is accessible within the IL-6 mRNA predicted secondary structure, characteristics associated with miRNA-mediated repression 28 . Previous studies indicated that miR-26b in naïve T cells contains non-genomic uridines on the 3 end 29 , supporting the postulate that miRNAs in this family, including miR-26b in particular, may be modified in the proposed manner. Northern blotting analyses demonstrated that miR-26b is expressed in A549 cells and its levels are not affected by Zcchc11 knockdown (Fig. 3b ). Transfection of A549 cells with miR-26b mimetics decreased TNF-α-induced IL-6 expression ( Fig. 3c ), demonstrating that this miRNA can repress IL-6. Consistently, blocking endogenous miR-26b using a mir-26b antisense inhibitor 30, 31 increased IL-6 expression ( Fig. 3d ). Blocking endogenous miR-26a also increased IL-6 expression ( Supplementary Information,  Fig. S4a ). Taken together, these gain-and loss-of-function approaches demonstrate that this family of miRNAs targets IL-6. Because the miR-26 mimetics showed less of a repressive effect on IL-6 than did Zcchc11 knockdown, miR-26 may be one of several miRNAs potentially modified by Zcchc11 to regulate IL-6 expression.
Zcchc11 was capable of uridylating miR-26b in vitro (Fig. 3e) . The enzyme showed a preference for single-stranded RNA rather than duplex, and this activity was abolished by point mutations in the nucleotidyltransferase domain (Fig. 3e ). Thus, Zcchc11 directly uridylates mature, single-stranded miRNAs, including miR-26b. To our knowledge, there is no evidence that sequence variations in the 3 ends of miRNAs affect their capability to repress targeted transcripts. Interestingly, we observed that 3 end uridylation of an miR-26b mimetic abrogated repression of IL-6 by this miRNA (Fig. 3f ). Uridylation of an miR-26a mimetic also resulted in its decreased ability to repress IL-6 expression ( Supplementary Information, Fig. S4b ). To test whether this was unique to the miR-26 targeting of IL-6, we transfected cells with uridylated mir-16 mimetics and assessed VEGF concentrations in the supernatant after TNF-α stimulation. We observed strong repression of VEGF by mir-16, as reported previously 32 , but this repression was not attenuated by mir-16 uridylation ( Supplementary Information,  Fig. S4c ). Additionally we sought to determine whether oligouridine tracts at miRNA 3 termini are capable of increasing IL-6 expression independent of sequence specificity, such as by functioning as ligands for TLR7 and TLR8 (ref. 33) . We found no differences in IL-6 production in the supernatants of TNF-stimulated cells treated with uridylated species of mir-16 ( Supplementary Information, Fig. S4d ). Taken together, these data suggest that uridylation of IL-6 mRNA-targeting miRNAs may be the mechanism by which Zcchc11 influences IL-6 expression.
We next determined whether the influence of Zcchc11 and miRNA on IL-6 expression involves direct interactions with the 3UTR of the IL-6 transcript. The IL-6 3UTR was sufficient to reduce protein expression in a luciferase reporter assay (Fig. 4a ). Importantly, this repressive effect of the IL-6 3UTR was exacerbated by Zcchc11 knockdown (Fig. 4a ). Furthermore, overexpression of Zcchc11 increased expression of the IL-6 3UTR-associated gene (Fig. 4b) . Mutating the nucleotidyltransferase domain of Zcchc11 significantly diminished these effects (Fig. 4b) . Thus, the ability of Zcchc11 to enhance IL-6 expression is mediated by the IL-6 3UTR and is dependent on Zcchc11 nucleotidyltransferase activity.
miR-26b gain-of-function further diminished expression associated with the IL-6 3UTR (Fig. 4c ). The addition of terminal uridines to this miRNA decreased its repressive activity towards the IL-6 3UTR (Fig. 4c ). Importantly, both the decreased expression driven by miR-26b and the counteracting increased expression resulting from its uridylation were abrogated by mutation of the predicted miRNA target site within the 3UTR (Fig. 4d ). Overall, these results demonstrate that the observed effects are direct results of miRNA interactions with the IL-6 3UTR.
Together, our data strongly suggest that Zcchc11 influences IL-6 expression by the untemplated uridylation of miR-26b or related IL-6 3UTR-targeting miRNAs. Thus, we deep sequenced small RNAs isolated from control and Zcchc11-knockdown cells to assess 3 terminal modifications of miR-26 family members. In A549 cells, miR-26a sequences were far more abundant than miR-26b (7,068 and 235 sequences recovered, respectively). Of the miR-26a sequences collected from control cells, most (74%) were the 22-nucleotide sequence reported in Fig. 3a , ending in a single uridine, which could be genomically encoded. An additional 4% of sequences contained 2 or 3, rather than 1, uridines at the end, which must necessarily represent untemplated uridylation ( Fig. 4e, Supplementary Information, Fig. S5 ).
Zcchc11-knockdown cells showed remarkably different results in that out of 10,306 miR-26a sequences collected, none were the sequence reported in Fig. 3a (control cells) . Instead, most (67%) were 21 nucleotides in length and were missing the terminal uridine ( Fig. 4e ), suggesting dicer cleavage of the mir-26a pre-miRNA at this nucleotide before Zcchc11-mediated uridylation in the control cells. For miR-26a sequences with definitively non-genomic uridines in the Zcchc11-knockdown cells, only 2 (0.02%) sequences ended in 2 uridines and none in 3 uridines. These data indicate that Zcchc11 mediates the addition of 1-3 uridines to the 3 terminus of miR-26a, defining a role for Zcchc11 in miRNA end modification.
Most (33%) of the remaining miR-26a sequences in the knockdown cells ended in UA (Fig. 4e) , which was also observed in the control cells, albeit with lower frequency (8%). One possible explanation for such a pattern could be that an enzyme which adds UA residues to miRNAs potentially competes with Zcchc11 for miR-26a modification. Alternatively, as adenylation of miRNAs increases miRNA stability 24 , it is conceivable that miR-26a that had been uridylated by Zcchc11 and then adenylated by GLD-2 or some other enzyme, but not non-adenylated forms of uridylated Zcchc11, may persist from before Zcchc11 was knocked down.
Not only were miR-26b sequences less common than miR-26a sequences, but the former also showed a distinct pattern of non-genomic end modification, with UA ends in 99% and 96% of miR-26b sequences from control and knockdown cells, respectively ( Supplementary Information, Fig. S6 ). On the basis of previous studies showing non-genomic uridine, but not UA, additions on miR-26b in T cells 29 , we suggest that the modifications of miRNAs are context-dependent. The identity of a putative UA-adding or adenylating enzyme in A549 cells and the significance of these nucleotide additions for miR-26b function remain to be determined.
The addition of non-templated nucleotides, most prominently uridine and adenine, at the 3 terminal ends of miRNAs has been observed in several species 34, 21, 35, 22, 23, 36, 37 . The mechanisms determining which miR-NAs are modified by Zcchc11, and under which circumstances, remain important avenues for future study. To our knowledge, this study provides the first identification of an enzyme responsible for the untemplated uridylation of mature miRNA. Such miRNA modifications are not simply by-products of processing, but rather they impart functional differences that attenuate miRNA-targeted repression. We further demonstrate this to be a means of post-transcriptionally regulating cytokine expression, potentially relevant to inflammation and immunity.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/.
Note: Supplementary Information is available on the Nature Cell Biology website.
AckNoWLeDgeMeNTS
We thank P. Sharp for access to the Koch Institute bioinformatics core and C. Whittaker, R. Plasmid construction and mutagenesis. Zcchc11 (accession no. NM_175472) was amplified by reverse transcription-PCR (RT-PCR) using RNA isolated from C57BL/6 mouse lungs. Full-length sequences were Flag-tagged and mutagenized using the QuikChange site-directed mutagenesis kit (Stratagene). For luciferase assays, the entire human IL-6 3UTR was PCR amplified from genomic DNA and cloned into the pMIR-REPORT luciferase reporter vector (Ambion) 38 . The IL-6 3UTR mutant contained two adenosines that were changed from uracil by site-directed mutagenesis to disrupt the first two miR-26 seed pairing with the target IL-6 sequence.
Nucleotidyltransferase assays. Flag-tagged wild-type and DADA mutant Zcchc11 (immunoprecipitated from transfected HEK 293T cells) 39 or endogenous Zcchc11 (immunoprecipitated from A549 cells) were incubated with RNA substrates and then electrophoresed in 6% TBE-Urea polyacrylamide gels. Endogenous Zcchc11 was immunoprecipitated after lysis (50 mM Tris HCl at pH 8.0, 150 mM NaCl and 1% NP-40) using a goat polyclonal anti-Zcchc11 antibody (Imgenex). Prewashed protein G Dynabeads (Invitrogen) were used for magnetic immunoprecipitations.
Immunoprecipitates (10 μl, estimated as 50-150 ng Zcchc11) were incubated for 30 min at 37 ºC in a total volume of 50 μl with [α-32 P] NTP (0.13 mM final concentration) and yeast tRNA (1 μg; Ambion), A 15 oligoribonucleotide (Invitrogen) or human RNA as substrates, or vehicle, together with RNAsin (40 U; Promega) in poly(A) polymerase buffer containing 25 mM Tris HCl at pH 7.0, 50 mM KCl, 0.7 mM MnCl 2 , 1 mM MgCl 2 , 0.2 mM EDTA, 100 μg ml -1 acetylated BSA and 10% glycerol (USB). Radiolabelled RNA was purified using Sephadex G-25 Quick Spin Columns (Roche). Samples were electrophoresed in 6% TBE-Urea polyacrylamide gels. Gels were dried under vacuum and exposed to radiographic film. Human non-coding RNA and poly(A) mRNA was fractionated from A549 cell total RNA using oligodeoxythymidylic acid cellulose and the Poly(A) Purist.
Measuring mRNA and protein. Human and murine cytokine and Zcchc11 mRNA contents were measured using real-time RT-PCR. Total RNA was extracted with Trizol (Life Technologies), and real-time RT-PCR was performed using the iScript One-Step RT-PCR Kit for Probes (Biorad) and the iCycler iQ Real-Time PCR detection system (Biorad). Probes contained the reporter dye 6-FAM at the 5 end and Black Hole Quencher-1 at the 3 end. For each sample, fold induction (versus control siRNA) was normalized to the content of 18S rRNA 40 . For immunoblotting, protein (20-45 μg) in lysates, from C57BL/6 mouse organs or cell cultures, in a buffer supplemented with 1X complete protease inhibitors (Roche) were treated with 3-8% tris-acetate SDS-PAGE and electroblotted onto Immobilon P transfer membranes. Antibodies used were against Flag M2 (Sigma), β-actin or pan actin (Cell Signaling), or a peptide from the carboxy terminus of human and mouse Zcchc11 (Imgenex). Flag M2 antibodies were used at a 1:2,000 dilution and the others, at a 1:1,000 dilution. mRNA decay, northern blotting and poly(A) tail length analysis. Before RNA collection, A549 cells were transfected with siRNA for 48 h and stimulated with TNF-α (10 ng ml -1 ) for 1 h. Transcription was inhibited, when indicated, using actinomycin D (5 μg ml -1 ) after 1 h of TNF-α exposure. mRNA levels were quantified using real-time RT-PCR. mRNA poly(A) tail length was assessed by H-northern, RACE-PAT (rapid amplification of cDNA ends poly(A) test), and LM-PAT (ligase-mediated poly(A) test) as described previously 18 . For H-northern assays, total RNA (20 μg) was digested with RNase H after hybridization with an IL-6-targeting anti-sense oligonucleotide (5-GTGTCCTAACGCTCATACTTTT-3). Select samples also included oligonucleotide (dT [12] [13] [14] [15] [16] [17] [18] ) for digestion of the poly(A) tails, as indicated. After digestion, RNA was electrophoresed on 6% polyacrylamide urea gels and transferred to nylon membranes. Membranes were hybridized to a 32 P-labelled IL-6 3UTRtargeting probe and exposed to radiographic film and densitometry (National Institutes for Health, ImageJ). The primers used to amplify this 3UTR probe were: sense 5-AAATATGTGAAGCTGAGTTAATTTATGTAAG-3 and antisense 5-AAAATGCCATTTATTGGTATAAAAACC -3. For RACE-PAT, total RNA (1 μg) was used for RT-PCR with an adaptor primer oligonucleotide (dT) anchor. PCR amplification products with the adaptor reverse primer and a forward primer specific to IL-6 mRNA (5-CTTTGTTTCAGAGCCAGATCATTT CTTG-3) were visualized on 2% agarose gels stained with ethidium bromide. For LM-PAT, total RNA (300 ng) was saturated with phosphorylated oligonucleotide (dT [12] [13] [14] [15] [16] [17] [18] ) and ligated with T4 DNA ligase (20 Weiss U; Promega) while annealed to mRNA poly(A) tails. A second ligation was sequentially performed with the addition of an adaptor primer oligonucleotide (dT 12 ) anchor at fivefold higher levels than oligo(dT [12] [13] [14] [15] [16] [17] [18] ) at 14 ºC for 2 h. The oligo-primed mRNA was then reversetranscribed with AMV RT (40 U; Promega). All enzymes were heat inactivated and RT cDNA was used for PCR amplification using an mRNA-specific sense primer and the adaptor primer oligonucleotide (dT 12 ).
Primer sequences.
For quantitative reverse transcription-PCR (qRT-PCR), primer and probe sequences were as follows: IL-6, sense 5-TGCAATAACC ACCCCTGACC-3, antisense 5-ATGCCCATTAACAACAACAATCTG-3 and probe 5-AC CACAAATG-CCAGCCTGCTGACG-3; IL-8, sense 5-CGGAAGGAACCATCTCACT-CTG-3, antisense 5-AG AAATCAGGAAGGCTGCC AAG -3 and probe 5-TGACTTCCAAGCTGGCCGTGGCTC-3; VEGF-A, sense 5-TGAGATCGAGTACATCTTCAAGCC-3, antisense 5-CTGAGGTTTGATCCGCATAATCTG-3 and probe 5-CCTGTGT-GCCCCTGATGCGATGCG-3;
G-CSF, sense 5-TTCCT-GGAGGTGTCGTACCG-3, antisense 5-TCCGTTCTGCTCTTCCCTGTC-3 and probe 5-TTCTACGCCACCTTGCCCAGCCCT-3; GM-CSF, sense 5-ATCTCAGAAATGTTTGACCTCCAG-3, antisense 5-TTC AAAGGTGATAATCTGGGTTGC-3 and probe 5-AGCCGACCTGCCTACAGA CCCGCC-3; TGF-α, sense 5-TTCGCTCTGGGTATTGTGTTG G-3, antisense 5-GGCAGTCATTAAAATGGGACACC-3 and probe 5-CCACGGGCGGGTCTGCACTCAGCG-3; murine Zcchc11, sense 5-AGAGTGAACTTCGTCTCTTCC-3, antisense 5-AACCATACAACCTCAGTGAACATTC-3 and probe 5-TCCTTC CTCTGCTCACTTGGCTGC-3. For H-northern assays, the IL-6 mRNA probe used for RNase H digestion was 5-GTGTCCTAACGCTCATACTTTT-3. For amplifying an IL-6 3UTR-specific probe used in H-northern assays, primers were: sense 5-AAATAT GTGAAGCTGAGTTAATTTATGTAAG-3 and antisense 5-AAAATGCCATTTATT GGTATAAAAACC-3. For IL-6 RACE-PAT analysis, the IL-6 sense primer 5-CTT TGTTTCAGAGCCAGATCATTTCTTG-3 and antisense adaptor primer 5-GCGAGCTCCGCGGCCGCG-T 12 -3were used. The same antisense adaptor primer was used for LM-PAT and the following mRNAspecific sense primers were used: 5-AATGGAAAGTGGCTATGCAGTTTGAA TATC-3 (IL-6), 5-GTTATCATT TATTTATTGGTGCTACTGTTTATCCG-3 (VEGF-A), 5-CTGTAATGTGTTAAT GTGATTAGCAGTTATTTTCC-3 (TGF-α), 5-GGGAGCTGCTCTCTCATGAAA CAAG-3 (GM-CSF) and 5-TTAGAACTATTAAAACAGCCAAAACTCCACAG-3 (IL-8).
miRNA isolation, cloning and northern analysis. Total RNA was extracted with Trizol (Invitrogen) and subsequently used for further purification using the mirVana miRNA isolation kit (Ambion), according to the manufacturer's instructions, to yield small RNAs < 200 nucleotides in length. For the library, small RNAs were pooled from four independent control and Zcchc11-knockdown A549 cells treated with TNF-α for 3 h. Detailed methods on library cloning are available on request. For northern blotting, small RNAs (1-2 μg per well) were loaded onto 15% PAGE urea gel and transferred to Brightstar-Plus Nylon membranes. Specific small RNAs were detected with polynucleotide kinase 32 P-labelled antisense oligonucleotides: 5-GCCATGCTAATCTTCTCTGTATC-3 (U6) and 5-ACCTATCCTGAATTACTTGAA-3 (mir-26b).
Deep sequencing. Short RNA cDNA libraries were run on an Illumina genome analyzer, and sequences were produced from IPAR data using Illumina pipeline 1.3.2. Individual reads were extracted from linker sequences, identical reads were collapsed to sequences and the sequences were queried against the human mature miRNA database from miRBase (release 13.0) using the BLAST algorithm. Analyses of miR-26a end modification included all sequences that demonstrated complete fidelity across the first 21 miR-26a nucleotides and that were free of contamination by sequences from the ligated adaptors. Complete lists of sequences collected for mir-26a and mir-26b, as well as several other miRNAs (demonstrating that the Zcchc11-dependent uridylation pattern observed for mir-26a was not ubiquitous), are available in Supplementary Information, Table S1 . miRNA mimetics and inhibitors. Transient transfections of A549 cells were performed as described above with the annealed mir-26b sense (miRBase accession number MIMAT0000083) 5-UUCAAGUAAUUCAGGAUAGGU-3 and antisense 5-CCUAUCCUGAAUUACUUGAAUU-3, with mir-26bU sense 5-UUCAAGUAAUUCAGGAUAGGUU-3 and antisense 5-CCUAUCCUGAAUUACUUGAAUU-3, or with mir-26bUUU sense 5-UUCAAGUAAUUCAGGAUAGGUUUU-3 and antisense 5-AACCUAUCCUGAAUUACUUGAAUU-3. For mir-26a, annealed sense (miRBase accession number MIMAT0000082) 5-UUCAAGUAAUCCAGGAUAGGC-3 and antisense 5-CUAUCCUGGAUUACUUGAAGC-3, with mir-26aU sense 5-UUCAAGUAAUCCAGGAUAGGCU-3 and antisense 5-CCUAUCCUGGAUUACUUGAACU-3, with mir-26aUUU sense 5-UUCAAGUAAUCCAGGAUAGGCUUU-3 and antisense 5-AGCCUAUCCUGGAUUACUUGAAUU-3. Duplexes and control non-targeting siRNA no. 1 were from Dharmacon. For mir-26b inhibition, miRIDIAN inhibitors specific to mir-26b and mir-26a2 were used to transfect A549 cells, as described above, along with the miRIDIAN miRNA inhibitor negative control no. 1 (Dharmacon).
Additional methods and reagents. Recombinant human TNF-α and matched antibody sets for ELISAs were from R&D Systems. The human cytokine/chemokines 30-plex immunoassay (Linco) was performed using Luminex100 on supernatants collected from A549 cells treated with non-specific and Zcchc11-targeting siRNA and subsequently stimulated with TNF-α (10 ng ml -1 ) for 24 h. Primary human samples were provided by S. Shore and L. Kobzik (both from the Harvard School of Public Health, USA).
Statistics. Data were presented as mean ± s.e.m. Statistical analyses were performed on data collected from at least three independent experiments. For comparisons across more than two groups (for example, multiple cytokines or time-points), analyses were performed using ANOVA. Data that failed Levene's test for homogeneity of variance were log-transformed before analyses. For comparisons of two groups, analyses were performed using Student's t-test. Differences were considered statistically significant when P < 0.05. Various polyadenylate tail lengths of IL-6 were examined and untemplated uracils were not detected.
Figure S5
Complete list of all mir-26a sequences obtained by deep sequencing of the miRNA libraries generated from Control and Zcchc11 siRNA treated cells. Mir-26a sequences are sorted in descending order based on the combined sequence sum obtained from both experimental groups. Supplemental Figure 6 
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